Closes in 14 daysOpportunity HT942526ATRPTRA

DoW Arthritis Translational Research Award

Defense Health Agency Contracting Activity - DHACA · Department of Defense

At a glance

DoW Arthritis Translational Research Award is an open federal grant opportunity from the Defense Health Agency Contracting Activity - DHACA (Department of Defense). Applications are due October 22, 2026. Total estimated funding is $1.6M across about 2 awards. The notice is unrestricted by applicant type, subject to any clarifications in the notice. Cost sharing is not required. It is funded under Assistance Listing 12.420 (Military Medical Research and Development).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

May 1, 2026Posted
Oct 22, 2026Application deadlinenext date
Nov 21, 2026Archived

Posted: May 1, 2026
Close date: Oct 22, 2026
Archive date: Nov 21, 2026
Award floor: Not specified
Award ceiling: Not specified
Est. total funding: $1,600,000
Expected awards: 2
Cost sharing: Not required
Funding instrument: Grant
Opportunity category: Discretionary

Who can apply

Unrestricted (any entity type)

Can your organization apply?

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

Summary: The fiscal year 2026 (FY26) Arthritis Research Program (ATRP) Translational Research Award (TRA) supports high-impact translational research that will accelerate critical findings into clinically relevant solutions. Research funded under this award mechanism will be hypothesis-driven, high-impact applied research that is relevant to Service Members, Veterans, their Families and the American public. Research addressing any and all types of arthritis is encouraged.

Distinctive Features: The FY26 ATRP TRA mechanism is intended to support preclinical or animal research and may not be used for clinical research or clinical trials. Basic research, as defined in Section 3.1.2, is not allowed. A key aspect of this award mechanism is impact. The application should explicitly state how outcomes of the proposed research will significantly advance arthritis research, particularly in accelerating critical findings into clinically relevant solutions.

Preliminary and/or published data, originating from research conducted by the applicant(s) or others, is required.

How to apply

0 of 8 done · progress saved in this browser

Read the full announcement (NOFO)Eligibility, evaluation criteria, page limits and required attachments are in the full notice on Grants.gov. Open ↗
Confirm eligibility and fitCheck your organization type above; no cost sharing is required.
Register (or renew) in SAM.gov and get a UEIFree. New registrations can take several weeks; registrations must be renewed every year. Open ↗
Set up Grants.gov accessCreate a Grants.gov account and make sure someone has the Authorized Organization Representative (AOR) role. Open ↗
Open the application packageUse opportunity number HT942526ATRPTRA on Grants.gov (Grants.gov Workspace). Open ↗
Prepare narrative, budget and attachmentsFollow the notice's format exactly — page limits and required forms are common reasons applications are rejected.
Ask the agency contact any questions earlyJoAnn Martin Grantor · help@eBRAP.org Open ↗
Submit before October 22, 2026Submit a few days early and keep your Grants.gov confirmation and validation emails.

Assistance Listing

What is an ALN?

12.420Military Medical Research and DevelopmentProgram →

Reported obligations under ALN 12.420

Historical data · not a prediction

FY24

$1.48B

FY25

$1.2B

FY26

— est.

Source: SAM.gov Assistance Listing 12.420. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

JoAnn Martin Grantor
help@eBRAP.org
301-619-2594

Quick answers

When is the deadline for “DoW Arthritis Translational Research Award”?

According to the official notice, applications are due October 22, 2026. Confirm the deadline and submission time on Grants.gov before applying.

Who is eligible to apply for “DoW Arthritis Translational Research Award”?

The notice lists eligibility as unrestricted — open to any type of entity — subject to clarifications in the notice's additional eligibility information.

How much funding is available through “DoW Arthritis Translational Research Award”?

Per the notice, total estimated program funding is $1,600,000 and the agency expects to make about 2 awards.

How do I apply for “DoW Arthritis Translational Research Award”?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity HT942526ATRPTRA), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

Closes in 7 daysALN 12.420